1 |
34977845 |
10.1016/j.xjidi.2021.100068 |
2022 |
Genomic Analysis of Cutaneous CD30-Positive Lymphoproliferative Disorders. |
SETD2 |
2 |
35030632 |
10.1182/bloodadvances.2021006410 |
2022 |
Distinct clinical and genetic features of hepatitis B virus-associated follicular lymphoma in Chinese patients. |
SETD2 |
3 |
35443279 |
10.1158/2159-8290.CD-21-1514 |
2022 |
SETD2 Haploinsufficiency Enhances Germinal Center-Associated AICDA Somatic Hypermutation to Drive B-cell Lymphomagenesis. |
SETD2 |
4 |
35459873 |
10.1038/s41375-022-01571-8 |
2022 |
Integrated clinical and genomic evaluation of guadecitabine (SGI-110) in peripheral T-cell lymphoma. |
SETD2 |
5 |
35522148 |
10.3324/haematol.2021.280005 |
2022 |
Focal structural variants revealed by whole genome sequencing disrupt the histone demethylase <i>KDM4C</i> in B cell lymphomas. |
SETD2 |
6 |
35551151 |
10.1097/PAS.0000000000001914 |
2022 |
Targeted Next-generation Sequencing Reveals a Wide Morphologic and Immunophenotypic Spectrum of Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma. |
SETD2 |
7 |
35708139 |
10.3324/haematol.2022.281226 |
2022 |
Monomorphic epitheliotropic intestinal T-cell lymphoma comprises morphologic and genomic heterogeneity impacting outcome. |
SETD2 |
8 |
35726023 |
10.1038/s41684-022-00998-x |
2022 |
The genomic landscape of canine diffuse large B-cell lymphoma identifies distinct subtypes with clinical and therapeutic implications. |
SETD2 |
9 |
35895386 |
10.1111/bjd.21791 |
2022 |
Primary cutaneous peripheral T-cell lymphomas with a T-follicular helper phenotype: an integrative clinical, pathological and molecular case series study. |
SETD2 |
10 |
35979577 |
10.3960/jslrt.22005 |
2022 |
Surface CD3-negative monomorphic epitheliotropic intestinal T-cell lymphoma. |
SETD2 |
11 |
34406703 |
10.1002/ajh.26324 |
2021 |
The clinical outcomes and genomic landscapes of acute lymphoblastic leukemia patients with E2A-PBX1: A 10-year retrospective study. |
SETD2 |
12 |
34576156 |
10.3390/ijms22189992 |
2021 |
Comparative Molecular Analysis of Primary Central Nervous System Lymphomas and Matched Vitreoretinal Lymphomas by Vitreous Liquid Biopsy. |
SETD2 |
13 |
34895266 |
10.1186/s13000-021-01173-5 |
2021 |
Clinicopathological and molecular genomic features of monomorphic epitheliotropic intestinal T-cell lymphoma in the Chinese population: a study of 20 cases. |
SETD2 |
14 |
31028364 |
10.1038/s41379-019-0279-8 |
2020 |
Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified. |
SETD2 |
15 |
31599770 |
10.1097/CCO.0000000000000590 |
2020 |
Novel molecular targets for the treatment of lung cancer. |
SETD2 |
16 |
31914529 |
10.3760/cma.j.issn.0529-5807.2020.01.004 |
2020 |
[Monomorphic epitheliotropic intestinal T-cell lymphoma: a clinicopathological analysis of twelve cases]. |
SETD2 |
17 |
32271188 |
10.1097/PAS.0000000000001470 |
2020 |
Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorders: A Clinical, Pathologic, and Molecular Study of 60 Cases Presenting With a Single Lesion: A Multicenter Study of the French Cutaneous Lymphoma Study Group. |
SETD2 |
18 |
32349779 |
10.1186/s13073-020-00739-0 |
2020 |
CEOP/IVE/GDP alternating regimen compared with CEOP as the first-line therapy for newly diagnosed patients with peripheral T cell lymphoma: results from a phase 2, multicenter, randomized, controlled clinical trial. |
SETD2 |
19 |
32469082 |
10.1002/cncr.32866 |
2020 |
Genome-defined African ancestry is associated with distinct mutations and worse survival in patients with diffuse large B-cell lymphoma. |
SETD2 |
20 |
32695399 |
10.1186/s40364-020-00205-4 |
2020 |
Plasma circulating tumor DNA assessment reveals <i>KMT2D</i> as a potential poor prognostic factor in extranodal NK/T-cell lymphoma. |
SETD2 |
21 |
32853382 |
10.1182/bloodadvances.2019000938 |
2020 |
The hematopoietic stem cell marker VNN2 is associated with chemoresistance in pediatric B-cell precursor ALL. |
SETD2 |
22 |
33260897 |
10.3390/cancers12123539 |
2020 |
Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma in Asia Frequently Shows <i>SETD2</i> Alterations. |
SETD2 |
23 |
30307363 |
10.1080/15384047.2018.1523857 |
2019 |
Successful implementation of genomically based treatment of chemotherapy refractory peripheral T-cell lymphoma (PTCL). |
SETD2 |
24 |
31221981 |
10.1038/s12276-019-0230-6 |
2019 |
The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism. |
SETD2 |
25 |
31344256 |
10.1111/bjh.16117 |
2019 |
The landscape of genetic mutations in patients with chronic lymphocytic leukaemia and complex karyotype. |
SETD2 |
26 |
31411343 |
10.1002/path.5333 |
2019 |
Genomic characterisation of breast fibroepithelial lesions in an international cohort. |
SETD2 |
27 |
28910456 |
10.1001/jamaoncol.2017.2918 |
2018 |
Identification of ALK Rearrangements in Malignant Peritoneal Mesothelioma. |
SETD2 |
28 |
29305415 |
10.3324/haematol.2017.182444 |
2018 |
Histone modifier gene mutations in peripheral T-cell lymphoma not otherwise specified. |
SETD2 |
29 |
29337025 |
10.1016/j.humpath.2018.01.005 |
2018 |
Hepatosplenic T-cell Lymphoma: a review of clinicopathologic features, pathogenesis, and prognostic factors. |
SETD2 |
30 |
29694893 |
10.1016/j.celrep.2018.03.124 |
2018 |
SETDB2 Links E2A-PBX1 to Cell-Cycle Dysregulation in Acute Leukemia through CDKN2C Repression. |
SETD2 |
31 |
28122867 |
10.1158/2159-8290.CD-16-0330 |
2017 |
The Genetic Basis of Hepatosplenic T-cell Lymphoma. |
SETD2 |
32 |
28373165 |
10.1158/2159-8290.CD-17-0160 |
2017 |
It Takes a Village to Unmask HSTL. |
SETD2 |
33 |
28424246 |
10.1084/jem.20160894 |
2017 |
Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2. |
SETD2 |
34 |
28612716 |
10.1051/medsci/20173305004 |
2017 |
[Molecular oncogenesis of lymphomas: role of the SETD2 gene in intestinal T-cell lymphomas]. |
SETD2 |
35 |
26527318 |
10.18632/oncotarget.6259 |
2016 |
Mutations in epigenetic regulators are involved in acute lymphoblastic leukemia relapse following allogeneic hematopoietic stem cell transplantation. |
SETD2 |
36 |
26829311 |
10.1016/j.jtho.2016.01.010 |
2016 |
KRAS and NKX2-1 Mutations in Invasive Mucinous Adenocarcinoma of the Lung. |
SETD2 |
37 |
26839360 |
10.1136/thoraxjnl-2015-207950 |
2016 |
A patient with complex multiple genomic ALK alterations. |
SETD2 |
38 |
27181063 |
10.1016/j.exphem.2016.04.011 |
2016 |
Comprehensive genomic analysis reveals FLT3 activation and a therapeutic strategy for a patient with relapsed adult B-lymphoblastic leukemia. |
SETD2 |
39 |
27218135 |
10.1080/1062936X.2016.1186112 |
2016 |
Investigation of the inhibitors of histone-lysine N-methyltransferase SETD2 for acute lymphoblastic leukaemia from traditional Chinese medicine. |
SETD2 |
40 |
27505670 |
10.1016/j.ccell.2016.07.006 |
2016 |
EZH2 and BCL6 Cooperate to Assemble CBX8-BCOR Complex to Repress Bivalent Promoters, Mediate Germinal Center Formation and Lymphomagenesis. |
SETD2 |
41 |
27600764 |
10.1038/ncomms12602 |
2016 |
Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations. |
SETD2 |
42 |
25444907 |
10.1016/j.canlet.2014.11.024 |
2015 |
Gene mutations in primary tumors and corresponding patient-derived xenografts derived from non-small cell lung cancer. |
SETD2 |
43 |
24662245 |
10.1038/ncomms4469 |
2014 |
Mutations in epigenetic regulators including SETD2 are gained during relapse in paediatric acute lymphoblastic leukaemia. |
SETD2 |
44 |
24710217 |
10.1038/ncomms4630 |
2014 |
The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes. |
SETD2 |
45 |
23065515 |
10.3324/haematol.2012.066977 |
2013 |
The role of a newly identified SET domain-containing protein, SETD3, in oncogenesis. |
SETD2 |
46 |
22237106 |
10.1038/nature10725 |
2012 |
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. |
SETD2 |